{
  "PMC": "7169511",
  "DOI": "10.1002/sita.200600115",
  "PMID": "32327963",
  "PMCID": "PMC7169511",
  "title": "Signal transduction in the type I interferon system and viral countermeasures.",
  "year": 2007,
  "source_url": "https://europepmc.org/article/PMC/PMC7169511",
  "source": "MED",
  "abstract_text": "Type I interferons (IFN) including IFNα/β are cytokines of the immune system with critical functions in innate and adaptive immune response. Secreted IFN acts via JAK/STAT signaling pathways to direct a huge gene expression program, including antiviral, apoptotic, survival and immune genes. Only recently, the molecular patterns and their receptors as well as the connected signaling pathways leading to transcriptional activation of IFN genes have been elucidated. Ubiquitous cytosolic RNA helicases like RIG-I which sense intracellular triphosphate RNAs and activate the IFN-controlling transcription factors IRF3 and IRF7 seem to play a major role in antiviral defense and immunity. Recognition of extracellular nucleic acids by a subset of Toll-like receptors in addition contributes to a generalized host IFN response. During co-evolution with the host, viruses have learned to counteract every piece of the IFN network. Learning from viruses how to target the IFN system may lead us to novel strategies for therapeutic intervention.",
  "full_text": "Signal Transduct Signal Transduct 10.1002/(ISSN)1615-4061 SITA Signal Transduction 1615-4053 1615-4061 WILEY‐VCH Verlag Weinheim 7169511 10.1002/sita.200600115 SITA200600115 Review Article Review Articles Signal transduction in the type I interferon system and viral countermeasures Brzózka Krzysztof 1 Pfaller Christian 1 Conzelmann Karl‐Klaus conzelma@lmb.uni-muenchen.de 1 Max‐von‐Pettenkofer Institute & Gene Center, Ludwig‐Maximilians‐Universität München, Munich, Germany. Fax: +49 (0)89 2180‐76899 02 2 2007 2 2007 7 1 10.1002/sita.v7:1 5 19 06 10 2006 11 12 2006 Copyright © 2007 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. Abstract Type I interferons (IFN) including IFNα/β are cytokines of the immune system with critical functions in innate and adaptive immune response. Secreted IFN acts via JAK/STAT signaling pathways to direct a huge gene expression program, including antiviral, apoptotic, survival and immune genes. Only recently, the molecular patterns and their receptors as well as the connected signaling pathways leading to transcriptional activation of IFN genes have been elucidated. Ubiquitous cytosolic RNA helicases like RIG‐I which sense intracellular triphosphate RNAs and activate the IFN‐controlling transcription factors IRF3 and IRF7 seem to play a major role in antiviral defense and immunity. Recognition of extracellular nucleic acids by a subset of Toll‐like receptors in addition contributes to a generalized host IFN response. During co‐evolution with the host, viruses have learned to counteract every piece of the IFN network. Learning from viruses how to target the IFN system may lead us to novel strategies for therapeutic intervention. innate immunity interferon IRF TLR RIG‐I Deutsche Forschungsgemeinschaft (SFB 455 “Viral functions and immune modulation”) Deutsche Forschungsgemeinschaft (Graduiertenkolleg 1202 “Oligonucleotides in cell biology and therapy”) source-schema-version-number 2.0 cover-date February 2007 details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020 References [1] Janeway , C.A. Jr. , ( 1989 ) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1: 1 – 13 . [2] Field , A.K. , Tytell , A.A. , Lampson , G.P. , Hilleman , M.R. ( 1967 ) Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl. Acad. Sci. U. S. A. 58 : 1004 – 1010 . 5233831 [3] Kerr , I.M. , Brown , R.E. , Ball , L.A. ( 1974 ) Increased sensitivity of cell‐free protein synthesis to double‐stranded RNA after interferon treatment. Nature 250 : 57 – 59 . 4366491 [4] Lebleu , B. , Sen , G.C. , Shaila , S. , Cabrer , B. , Lengyel , P. ( 1976 ) Interferon, double‐stranded RNA, and protein phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 73 : 3107 – 3111 . 1067606 [5] Yoneyama , M. , Kikuchi , M. , Matsumoto , K. , Imaizumi , T. , et al. ( 2005 ) Shared and unique functions of the DExD/H‐box helicases RIG‐I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175 : 2851 – 2858 . 16116171 [6] Yoneyama , M. , Kikuchi , M. , Natsukawa , T. , Shinobu , N. , et al. ( 2004 ) The RNA helicase RIG‐I has an essential function in double‐stranded RNA‐induced innate antiviral responses. Nat. Immunol. 5 : 730 – 737 . 15208624 [7] Andrejeva , J. , Childs , K.S. , Young , D.F. , Carlos , T.S. , et al. ( 2004 ) The V proteins of paramyxoviruses bind the IFN‐inducible RNA helicase, mda‐5, and inhibit its activation of the IFN‐beta promoter. Proc. Natl. Acad. Sci. U. S. A. 101 : 17264 – 17269 . 15563593 [8] Rothenfusser , S. , Goutagny , N. , DiPerna , G. , Gong , M. , et al. ( 2005 ) The RNA helicase Lgp2 inhibits TLR‐independent sensing of viral replication by retinoic acid‐inducible gene‐I. J. Immunol. 175 : 5260 – 5268 . 16210631 [9] Komuro , A. , Horvath , C.M. ( 2006 ) RNA‐ and Virus‐Independent Inhibition of Antiviral Signaling by RNA Helicase LGP2. J. Virol. 80 : 12332 – 12342 . 17020950 [10] Weber , F. , Wagner , V. , Rasmussen , S.B. , Hartmann , R. , Paludan , S.R. ( 2006 ) Double‐stranded RNA is produced by positive‐strand RNA viruses and DNA viruses but not in detectable amounts by negative‐strand RNA viruses. J. Virol. 80 : 5059 – 5064 . 16641297 [11] Kato , H. , Takeuchi , O. , Sato , S. , Yoneyama , M. , et al. ( 2006 ) Differential roles of MDA5 and RIG‐I helicases in the recognition of RNA viruses. Nature 441 : 101 – 105 . 16625202 [12] Kato , H. , Sato , S. , Yoneyama , M. , Yamamoto , M. , et al. ( 2005 ) Cell type‐specific involvement of RIG‐I in antiviral response. Immunity 23 : 19 – 28 . 16039576 [13] Gitlin , L. , Barchet , W. , Gilfillan , S. , Cella , M. , et al. ( 2006 ) Essential role of mda‐5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103 : 8459 – 8464 . 16714379 [14] Kumar , H. , Kawai , T. , Kato , H. , Sato , S. , et al. ( 2006 ) Essential role of IPS‐1 in innate immune responses against RNA viruses. J. Exp. Med. 203 : 1795 – 1803 . 16785313 [15] Sun , Q. , Sun , L. , Liu , H.H. , Chen , X. , et al. ( 2006 ) The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24 : 633 – 642 . 16713980 [16] Marques , J.T. , Devosse , T. , Wang , D. , Zamanian‐Daryoush , M. , et al. ( 2006 ) A structural basis for discriminating between self and nonself double‐stranded RNAs in mammalian cells. Nat. Biotechnol. 24 : 559 – 565 . 16648842 [17] Kim , D.H. , Longo , M. , Han , Y. , Lundberg , P. , et al. ( 2004 ) Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22 : 321 – 325 . 14990954 [18] Hornung , V. , Ellegast , J. , Kim , S. , Brzozka , K. , et al. ( 2006 ) 5′‐Triphosphate RNA is the ligand for RIG‐I. Science 314 : 994 – 997 . 17038590 [19] Pichlmair , A. , Schulz , O. , Tan , C.P. , Naslund , T.I. , et al. ( 2006 ) RIG‐I‐mediated antiviral responses to single‐stranded RNA bearing 5′‐phosphates. Science 314 : 997 – 1001 . 17038589 [20] Hornung , V. , Guenthner‐Biller , M. , Bourquin , C. , Ablasser , A. , et al. ( 2005 ) Sequence‐specific potent induction of IFN‐alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 : 263 – 270 . 15723075 [21] Kawai , T. , Takahashi , K. , Sato , S. , Coban , C. , et al. ( 2005 ) IPS‐1, an adaptor triggering RIG‐I‐ and Mda5‐mediated type I interferon induction. Nat. Immunol. 6 : 981 – 988 . 16127453 [22] Seth , R.B. , Sun , L. , Ea , C.K. , Chen , Z.J. ( 2005 ) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF‐kappaB and IRF 3. Cell 122 : 669 – 682 . 16125763 [23] Xu , L.G. , Wang , Y.Y. , Han , K.J. , Li , L.Y. , et al. ( 2005 ) VISA is an adapter protein required for virus‐triggered IFN‐beta signaling. Mol. Cell 19 : 727 – 740 . 16153868 [24] Meylan , E. , Curran , J. , Hofmann , K. , Moradpour , D. , et al. ( 2005 ) Cardif is an adaptor protein in the RIG‐I antiviral pathway and is targeted by hepatitis C virus. Nature 437 : 1167 – 1172 . 16177806 [25] Loo , Y.M. , Owen , D.M. , Li , K. , Erickson , A.K. , et al. ( 2006 ) Viral and therapeutic control of IFN‐beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 103 : 6001 – 6006 . 16585524 [26] Saha , S.K. , Pietras , E.M. , He , J.Q. , Kang , J.R. , et al. ( 2006 ) Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25 : 3257 – 3263 . 16858409 [27] Oganesyan , G. , Saha , S.K. , Guo , B. , He , J.Q. , et al. ( 2006 ) Critical role of TRAF3 in the Toll‐like receptor‐dependent and ‐independent antiviral response. Nature 439 : 208 – 211 . 16306936 [28] Hacker , H. , Redecke , V. , Blagoev , B. , Kratchmarova , I. , et al. ( 2006 ) Specificity in Toll‐like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 : 204 – 207 . 16306937 [29] Saha , S.K. , Cheng , G. ( 2006 ) TRAF3: a new regulator of type I interferons. Cell Cycle 5 : 804 – 807 . 16582590 [30] Lin , R. , Yang , L. , Nakhaei , P. , Sun , Q. , et al. ( 2006 ) Negative regulation of the retinoic acid‐inducible gene I‐induced antiviral state by the ubiquitin‐editing protein A20. J. Biol. Chem. 281 : 2095 – 2103 . 16306043 [31] Wang , Y.Y. , Li , L. , Han , K.J. , Zhai , Z. , Shu , H.B. ( 2004 ) A20 is a potent inhibitor of TLR3‐ and Sendai virus‐induced activation of NF‐kappaB and ISRE and IFN‐beta promoter. FEBS Lett. 576 : 86 – 90 . 15474016 [32] Ishii , K.J. , Coban , C. , Kato , H. , Takahashi , K. , et al. ( 2006 ) A Toll‐like receptor‐independent antiviral response induced by double‐stranded B‐form DNA. Nat. Immunol. 7 : 40 – 48 . 16286919 [33] Okabe , Y. , Kawane , K. , Akira , S. , Taniguchi , T. , Nagata , S. ( 2005 ) Toll‐like receptor‐independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202 : 1333 – 1339 . 16301743 [34] Stetson , D.B. , Medzhitov , R. ( 2006 ) Recognition of cytosolic DNA activates an IRF3‐dependent innate immune response. Immunity 24 : 93 – 103 . 16413926 [35] O'Riordan , M. , Yi , C.H. , Gonzales , R. , Lee , K.D. , Portnoy , D.A. ( 2002 ) Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. U. S. A. 99 : 13861 – 13866 . 12359878 [36] Honda , K. , Taniguchi , T. ( 2006 ) IRFs: master regulators of signalling by Toll‐like receptors and cytosolic pattern‐recognition receptors. Nat. Rev. Immunol. 6 : 644 – 658 . 16932750 [37] Maniatis , T. , Falvo , J.V. , Kim , T.H. , Kim , T.K. , et al. ( 1998 ) Structure and function of the interferon‐beta enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63 : 609 – 620 . 10384326 [38] Yoneyama , M. , Suhara , W. , Fukuhara , Y. , Fukuda , M. , et al. ( 1998 ) Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF‐3 and CBP/p300. EMBO J. 17 : 1087 – 1095 . 9463386 [39] Sharma , S. , Tenoever , B.R. , Grandvaux , N. , Zhou , G.P. , et al. ( 2003 ) Triggering the interferon antiviral response through an IKK‐related pathway. Science 300 : 1148 – 1151 . 12702806 [40] Fitzgerald , K.A. , McWhirter , S.M. , Faia , K.L. , Rowe , D.C. , et al. ( 2003 ) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 : 491 – 496 . 12692549 [41] McWhirter , S.M. , Fitzgerald , K.A. , Rosains , J. , Rowe , D.C. , et al. ( 2004 ) IFN‐regulatory factor 3‐dependent gene expression is defective in Tbk1‐deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 101 : 233 – 238 . 14679297 [42] Huang , J. , Liu , T. , Xu , L.G. , Chen , D. , et al. ( 2005 ) SIKE is an IKK epsilon/TBK1‐associated suppressor of TLR3‐ and virus‐triggered IRF‐3 activation pathways. EMBO J. 24 : 4018 – 4028 . 16281057 [43] Obata , Y. , Yamamoto , K. , Miyazaki , M. , Shimotohno , K. , et al. ( 2005 ) Role of cyclophilin B in activation of interferon regulatory factor‐3. J. Biol. Chem. 280 : 18355 – 18360 . 15764595 [44] Yang , K. , Shi , H. , Qi , R. , Sun , S. , et al. ( 2006 ) Hsp90 regulates activation of interferon regulatory factor 3 and TBK‐1 stabilization in Sendai virus‐infected cells. Mol. Biol. Cell 17 : 1461 – 1471 . 16394098 [45] Sato , M. , Suemori , H. , Hata , N. , Asagiri , M. , et al. ( 2000 ) Distinct and essential roles of transcription factors IRF‐3 and IRF‐7 in response to viruses for IFN‐alpha/beta gene induction. Immunity 13 : 539 – 548 . 11070172 [46] Saitoh , T. , Tun‐Kyi , A. , Ryo , A. , Yamamoto , M. , et al. ( 2006 ) Negative regulation of interferon‐regulatory factor 3‐dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7 : 598 – 605 . 16699525 [47] Lu , G. , Reinert , J.T. , Pitha‐Rowe , I. , Okumura , A. , et al. ( 2006 ) ISG15 enhances the innate antiviral response by inhibition of IRF‐3 degradation. Cell Mol. Biol. 52 : 29 – 41 . 16914094 [48] Akira , S. , Takeda , K. ( 2004 ) Toll‐like receptor signalling. Nat. Rev. Immunol. 4 : 499 – 511 . 15229469 [49] Alexopoulou , L. , Holt , A.C. , Medzhitov , R. , Flavell , R.A. ( 2001 ) Recognition of double‐stranded RNA and activation of NF‐kappaB by Toll‐like receptor 3. Nature 413 : 732 – 738 . 11607032 [50] Heil , F. , Hemmi , H. , Hochrein , H. , Ampenberger , F. , et al. ( 2004 ) Species‐specific recognition of single‐stranded RNA via toll‐like receptor 7 and 8. Science 303 : 1526 – 1529 . 14976262 [51] Hemmi , H. , Takeuchi , O. , Kawai , T. , Kaisho , T. , et al. ( 2000 ) A Toll‐like receptor recognizes bacterial DNA. Nature 408 : 740 – 745 . 11130078 [52] Wagner , H. ( 2004 ) The immunobiology of the TLR9 subfamily. Trends Immunol. 25 : 381 – 386 . 15207506 [53] Kawai , T. , Akira , S. ( 2006 ) Innate immune recognition of viral infection. Nat. Immunol. 7 : 131 – 137 . 16424890 [54] Hornung , V. , Rothenfusser , S. , Britsch , S. , Krug , A. ( 2002 ) Quantitative expression of toll‐like receptor 1‐10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168 : 4531 – 4537 . 11970999 [55] Fitzgerald‐Bocarsly , P. ( 2002 ) Natural interferon‐alpha producing cells: the plasmacytoid dendritic cells. Biotechniques Suppl : 16 – 19 . [56] Barchet , W. , Cella , M. , Odermatt , B. , Asselin‐Paturel , C. , et al. ( 2002 ) Virus‐induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 195 : 507 – 516 . 11854363 [57] Colonna , M. , Trinchieri , G. , Liu , Y.J. ( 2004 ) Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5 : 1219 – 1226 . 15549123 [58] Yamamoto , M. , Sato , S. , Hemmi , H. , Hoshino , K. , et al. ( 2003 ) Role of adaptor TRIF in the MyD88‐independent toll‐like receptor signaling pathway. Science 301 : 640 – 643 . 12855817 [59] Oshiumi , H. , Matsumoto , M. , Funami , K. , Akazawa , T. , Seya , T. ( 2003 ) TICAM‐1, an adaptor molecule that participates in Toll‐like receptor 3‐mediated interferon‐beta induction. Nat. Immunol. 4 : 161 – 167 . 12539043 [60] Fitzgerald , K.A. , Rowe , D.C. , Barnes , B.J. , Caffrey , D.R. , et al. ( 2003 ) LPS‐TLR4 signaling to IRF‐3/7 and NF‐kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198 : 1043 – 1055 . 14517278 [61] Yamamoto , M. , Sato , S. , Hemmi , H. , Uematsu , S. , et al. ( 2003 ) TRAM is specifically involved in the Toll‐like receptor 4‐mediated MyD88‐independent signaling pathway. Nat. Immunol. 4 : 1144 – 1150 . 14556004 [62] Honda , K. , Yanai , H. , Mizutani , T. , Negishi , H. , et al. ( 2004 ) Role of a transductional‐transcriptional processor complex involving MyD88 and IRF‐7 in Toll‐like receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 101 : 15416 – 15421 . 15492225 [63] Kawai , T. , Sato , S. , Ishii , K.J. , Coban , C. , et al. ( 2004 ) Interferon‐alpha induction through Toll‐like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5 : 1061 – 1068 . 15361868 [64] Yang , K. , Puel , A. , Zhang , S. , Eidenschenk , C. , et al. ( 2005 ) Human TLR‐7‐, ‐8‐, and ‐9‐mediated induction of IFN‐alpha/beta and ‐lambda is IRAK‐4 dependent and redundant for protective immunity to viruses. Immunity 23 : 465 – 478 . 16286015 [65] Uematsu , S. , Sato , S. , Yamamoto , M. , Hirotani , T. , et al. ( 2005 ) Interleukin‐1 receptor‐associated kinase‐1 plays an essential role for Toll‐like receptor (TLR)7‐ and TLR9‐mediated interferon‐{alpha} induction. J. Exp. Med. 201 : 915 – 923 . 15767370 [66] Hoshino , K. , Sugiyama , T. , Matsumoto , M. , et al. ( 2006 ) IkappaB kinase‐alpha is critical for interferon‐alpha production induced by Toll‐like receptors 7 and 9. Nature 440 : 949 – 953 . 16612387 [67] Akira , S. , Takeda , K. ( 2004 ) Functions of toll‐like receptors: lessons from KO mice. C. R. Biol. 327 : 581 – 589 . 15330257 [68] Stetson , D.B. , Medzhitov , R. ( 2006 ) Antiviral defense: interferons and beyond. J. Exp. Med. 203 : 1837 – 1841 . 16880263 [69] Boxel‐Dezaire , A.H. , Rani , M.R. , Stark , G.R. ( 2006 ) Complex modulation of cell type‐specific signaling in response to type I interferons. Immunity 25 : 361 – 372 . 16979568 [70] Platanias , L.C. ( 2005 ) Mechanisms of type‐I‐ and type‐II‐interferon‐mediated signalling. Nat. Rev. Immunol. 5 : 375 – 386 . 15864272 [71] Stark , G.R. , Kerr , I.M. , Williams , B.R. , Silverman , R.H. , Schreiber , R.D. ( 1998 ) How cells respond to interferons. Annu. Rev. Biochem. 67 : 227 – 264 . 9759489 [72] Darnell , J.E. Jr. , Kerr , I.M. , Stark , G.R. ( 1994 ) Jak‐STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 : 1415 – 1421 . 8197455 [73] Velazquez , L. , Fellous , M. , Stark , G.R. , Pellegrini , S. ( 1992 ) A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70 : 313 – 322 . 1386289 [74] Kubo , M. , Hanada , T. , Yoshimura , A. ( 2003 ) Suppressors of cytokine signaling and immunity. Nat. Immunol. 4 : 1169 – 1176 . 14639467 [75] Shuai , K. , Liu , B. ( 2005 ) Regulation of gene‐activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5 : 593 – 605 . 16056253 [76] Goodbourn , S. , Didcock , L. , Randall , R.E. ( 2000 ) Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81 : 2341 – 2364 . 10993923 [77] Samuel , C.E. ( 2001 ) Antiviral actions of interferons. Clin. Microbiol. Rev. 14 : 778 – 809 . 11585785 [78] Weber , F. , Kochs , G. , Haller , O. ( 2004 ) Inverse interference: how viruses fight the interferon system. Viral Immunol. 17 : 498 – 515 . 15671747 [79] Williams , B.R. ( 1999 ) PKR; a sentinel kinase for cellular stress. Oncogene 18 : 6112 – 6120 . 10557102 [80] Silverman , R.H. ( 1994 ) Fascination with 2‐5A‐dependent RNase: a unique enzyme that functions in interferon action. J Interferon Res. 14 : 101 – 104 . 7523539 [81] Haller , O. , Kochs , G. ( 2002 ) Interferon‐induced mx proteins: dynamin‐like GTPases with antiviral activity. Traffic 3 : 710 – 717 . 12230469 [82] Sheehy , A.M. , Gaddis , N.C. , Malim , M.H. ( 2003 ) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV‐1 Vif. Nat. Med. 9 : 1404 – 1407 . 14528300 [83] Chiu , Y.L. , Soros , V.B. , Kreisberg , J.F. , Stopak , K. , et al. ( 2005 ) Cellular APOBEC3G restricts HIV‐1 infection in resting CD4+ T cells. Nature 435 : 108 – 114 . 15829920 [84] Durbin , J.E. , Hackenmiller , R. , Simon , M.C. , Levy , D.E. ( 1996 ) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84 : 443 – 450 . 8608598 [85] Park , C. , Li , S. , Cha , E. , Schindler , C. ( 2000 ) Immune response in Stat2 knockout mice. Immunity 13 : 795 – 804 . 11163195 [86] van den Broek , M.F. , Muller , U. , Huang , S. , Zinkernagel , R.M. , Aguet , M. ( 1995 ) Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148 : 5 – 18 . 8825279 [87] Li , S. , Min , J.Y. , Krug , R.M. , Sen , G.C. ( 2006 ) Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double‐stranded RNA. Virology 349 : 13 – 21 . 16466763 [88] Noah , D.L. , Twu , K.Y. , Krug , R.M. ( 2003 ) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre‐mRNAS. Virology 307 : 386 – 395 . 12667806 [89] Garcia‐Sastre , A. , Biron , C.A. ( 2006 ) Type 1 interferons and the virus‐host relationship: a lesson in detente. Science 312 : 879 – 882 . 16690858 [90] Cardenas , W.B. , Loo , Y.M. , Gale , M. Jr. , Hartman , A.L. , et al. ( 2006 ) Ebola virus VP35 protein binds double‐stranded RNA and inhibits alpha/beta interferon production induced by RIG‐I signaling. J. Virol. 80 : 5168 – 5178 . 16698997 [91] Chang , H.W. , Watson , J.C. , Jacobs , B.L. ( 1992 ) The E3L gene of vaccinia virus encodes an inhibitor of the interferon‐induced, double‐stranded RNA‐dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 89 : 4825 – 4829 . 1350676 [92] Langland , J.O. , Kash , J.C. , Carter , V. , Thomas , M.J. , et al. ( 2006 ) Suppression of Proinflammatory Signal Transduction and Gene Expression by the Dual Nucleic Acid Binding Domains of the Vaccinia Virus E3L Proteins. J. Virol. 80 : 10083 – 10095 . 17005686 [93] Haga , I.R. , Bowie , A.G. ( 2005 ) Evasion of innate immunity by vaccinia virus. Parasitology 130 Suppl:: S11 – S25 . 16281988 [94] Iqbal , M. , Poole , E. , Goodbourn , S. , McCauley , J.W. ( 2004 ) Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of beta interferon by double‐stranded RNA. J. Virol. 78 : 136 – 145 . 14671095 [95] Childs , K. , Stock , N. , Ross , C. , Andrejeva , J. , et al. ( 2006 ) mda‐5, but not RIG‐I, is a common target for paramyxovirus V proteins. Virology Oct 13; [Epub ahead of print]. [96] Hornung , V. , Schlender , J. , Guenthner‐Biller , M. , Rothenfusser , S. , et al. ( 2004 ) Replication‐dependent potent IFN‐alpha induction in human plasmacytoid dendritic cells by a single‐stranded RNA virus. J. Immunol. 173 : 5935 – 5943 . 15528327 [97] Li , K. , Foy , E. , Ferreon , J.C. , Nakamura , M. , et al. ( 2005 ) Immune evasion by hepatitis C virus NS3/4A protease‐mediated cleavage of the Toll‐like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. U. S. A. 102 : 2992 – 2997 . 15710891 [98] Chen , Z. , Benureau , Y. , Rijnbrand , R. , Yi , J. , et al. ( 2006 ) GB virus B Disrupts RIG‐I Signaling by NS3/4A‐mediated Cleavage of the Adaptor Protein MAVS. J. Virol. 81 : 964 – 976 . 17093192 [99] Stack , J. , Haga , I.R. , Schroder , M. , Bartlett , N.W. , et al. ( 2005 ) Vaccinia virus protein A46R targets multiple Toll‐like‐interleukin‐1 receptor adaptors and contributes to virulence. J. Exp. Med. 201 : 1007 – 1018 . 15767367 [100] Unterstab , G. , Ludwig , S. , Anton , A. , Planz , O. , et al. ( 2005 ) Viral targeting of the interferon‐{beta}‐inducing Traf family member‐associated NF‐{kappa}B activator (TANK)‐binding kinase‐1. Proc. Natl. Acad. Sci. U. S. A. 102 : 13640 – 13645 . 16155125 [101] Brzózka , K. , Finke , S. , Conzelmann , K.K. ( 2005 ) Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79 : 7673 – 7681 . 15919920 [102] Mori , M. , Yoneyama , M. , Ito , T. , Takahashi , K. , et al. ( 2004 ) Identification of Ser‐386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 279 : 9698 – 9702 . 14703513 [103] Vidy , A. , Chelbi‐Alix , M. , Blondel , D. ( 2005 ) Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 79 : 14411 – 14420 . 16254375 [104] Brzózka , K. , Finke , S. , Conzelmann , K.K. ( 2006 ) Inhibition of interferon signaling by rabies virus phosphoprotein P: activation‐dependent binding of STAT1 and STAT2. J. Virol. 80 : 2675 – 2683 . 16501077 [105] Hartman , A.L. , Dover , J.E. , Towner , J.S. , Nichol , S.T. ( 2006 ) Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF‐3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF‐3 activation without inhibiting viral transcription or replication. J. Virol. 80 : 6430 – 6440 . 16775331 [106] Bossert , B. , Marozin , S. , Conzelmann , K.K. ( 2003 ) Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J. Virol. 77 : 8661 – 8668 . 12885884 [107] Spann , K.M. , Tran , K.C. , Chi , B. , Rabin , R.L. , Collins , P.L. ( 2004 ) Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J. Virol. 78 : 4363 – 4369 . 15047850 [108] Schlender , J. , Bossert , B. , Buchholz , U. , Conzelmann , K.K. ( 2000 ) Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon‐induced antiviral response. J. Virol. 74 : 8234 – 8242 . 10954520 [109] Bossert , B. , Conzelmann , K.K. ( 2002 ) Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon‐competent bovine cells. J. Virol. 76 : 4287 – 4293 . 11932394 [110] Alff , P.J. , Gavrilovskaya , I.N. , Gorbunova , E. , Endriss , K. , et al. ( 2006 ) The Pathogenic NY‐1 Hantavirus G1 Cytoplasmic Tail Inhibits RIG‐I‐ and TBK‐1‐Directed Interferon Responses. J. Virol. 80 : 9676 – 9686 . 16973572 [111] Kopecky‐Bromberg , S.A. , Martinez‐Sobrido , L. , Frieman , M. , Baric , R.A. , Palese , P. ( 2006 ) SARS coronavirus proteins ORF 3B, ORF 6, and nucleocapsid function as interferon antagonists. J. Virol. 81 : 548 – 557 . 17108024 [112] Jennings , S. , Martinez‐Sobrido , L. , Garcia‐Sastre , A. , Weber , F. , Kochs , G. ( 2005 ) Thogoto virus ML protein suppresses IRF3 function. Virology 331 : 63 – 72 . 15582653 [113] La Rocca , S.A. , Herbert , R.J. , Crooke , H. , Drew , T.W. , et al. ( 2005 ) Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N‐terminal protease, Npro. J. Virol. 79 : 7239 – 7247 . 15890962 [114] Hilton , L. , Moganeradj , K. , Zhang , G. , Chen , Y.H. , et al. ( 2006 ) The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J. Virol. 80 : 11723 – 11732 . 16971436 [115] Barro , M. , Patton , J.T. ( 2005 ) Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. U. S. A. 102 : 4114 – 4119 . 15741273 [116] Hahn , A.M. , Huye , L.E. , Ning , S. , Webster‐Cyriaque , J. , Pagano , J.S. ( 2005 ) Interferon regulatory factor 7 is negatively regulated by the Epstein‐Barr virus immediate‐early gene, BZLF‐1. J. Virol. 79 : 10040 – 10052 . 16014964 [117] Lin , R. , Genin , P. , Mamane , Y. , Sgarbanti , M. , et al. ( 2001 ) HHV‐8 encoded vIRF‐1 represses the interferon antiviral response by blocking IRF‐3 recruitment of the CBP/p300 coactivators. Oncogene 20 : 800 – 811 . 11314014 [118] Lubyova , B. , Kellum , M.J. , Frisancho , A.J. , Pitha , P.M. ( 2004 ) Kaposi's sarcoma‐associated herpesvirus‐encoded vIRF‐3 stimulates the transcriptional activity of cellular IRF‐3 and IRF‐7. J. Biol. Chem. 279 : 7643 – 7654 . 14668346 [119] Seo , T. , Park , J. , Lim , C. , Choe , J. ( 2004 ) Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma‐associated herpesvirus. Oncogene 23 : 6146 – 6155 . 15208654 [120] Schlender , J. , Hornung , V. , Finke , S. , Gunthner‐Biller , M. , et al. ( 2005 ) Inhibition of toll‐like receptor 7‐ and 9‐mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J. Virol. 79 : 5507 – 5515 . 15827165 [121] Moss , W.J. , Ota , M.O. , Griffin , D.E. ( 2004 ) Measles: immune suppression and immune responses. Int. J Biochem. Cell Biol. 36 : 1380 – 1385 . 15147716 [122] Symons , J.A. , Alcami , A. , Smith , G.L. ( 1995 ) Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81 : 551 – 560 . 7758109 [123] Alcami , A. , Symons , J.A. , Smith , G.L. ( 2000 ) The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J. Virol. 74 : 11230 – 11239 . 11070021 [124] Li , S. , Labrecque , S. , Gauzzi , M.C. , Cuddihy , A.R. , et al. ( 1999 ) The human papilloma virus (HPV)‐18 B oncoprotein physically associates with Tyk2 and impairs Jak‐STAT activation by interferon‐alpha. Oncogene 18 : 5727 – 5737 . 10523853 [125] Didcock , L. , Young , D.F. , Goodbourn , S. , Randall , R.E. ( 1999 ) The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome‐mediated degradation. J. Virol. 73 : 9928 – 9933 . 10559305 [126] Ulane , C.M. , Kentsis , A. , Cruz , C.D. , Parisien , J.P. , et al. ( 2005 ) Composition and assembly of STAT‐targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. J. Virol. 79 : 10180 – 10189 . 16051811 [127] Garcin , D. , Marq , J.B. , Strahle , L. , le Mercier , P. , Kolakofsky , D. ( 2002 ) All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono‐ubiquitination and degradation. Virology 295 : 256 – 265 . 12033784 [128] Gotoh , B. , Komatsu , T. , Takeuchi , K. , Yokoo , J. ( 2002 ) Paramyxovirus strategies for evading the interferon response. Rev. Med. Virol 12 : 337 – 357 . 12410527 [129] Ramaswamy , M. , Shi , L. , Varga , S.M. , Barik , S. , et al. ( 2006 ) Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344 : 328 – 339 . 16216295 [130] Lo , M.S. , Brazas , R.M. , Holtzman , M.J. ( 2005 ) Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J. Virol. 79 : 9315 – 9319 . 15994826 [131] Horvath , C.M. ( 2004 ) Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur. J Biochem. 271 : 4621 – 4628 . 15606749 [132] Nagai , Y. , Kato , A. ( 2004 ) Accessory genes of the paramyxoviridae, a large family of nonsegmented negative‐strand RNA viruses, as a focus of active investigation by reverse genetics. Curr. Top. Microbiol. Immunol. 283 : 197 – 248 . 15298171 [133] Reid , S.P. , Leung , L.W. , Hartman , A.L. , Martinez , O. , et al. ( 2006 ) Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80 : 5156 – 5167 . 16698996 [134] Leonard , G.T. , Sen , G.C. ( 1996 ) Effects of adenovirus E1A protein on interferon‐signaling. Virology 224 : 25 – 33 . 8862396 [135] Look , D.C. , Roswit , W.T. , Frick , A.G. , Gris‐Alevy , Y. , et al. ( 1998 ) Direct suppression of Stat1 function during adenoviral infection. Immunity 9 : 871 – 880 . 9881977 [136] Paulus , C. , Krauss , S. , Nevels , M. ( 2006 ) A human cytomegalovirus antagonist of type I IFN‐dependent signal transducer and activator of transcription signaling. Proc. Natl. Acad. Sci. U. S. A. 103 : 3840 – 3845 . 16497831 [137] Zimmermann , A. , Trilling , M. , Wagner , M. , Wilborn , M. , et al. ( 2005 ) A cytomegaloviral protein reveals a dual role for STAT2 in IFN‐{gamma} signaling and antiviral responses. J. Exp. Med. 201 : 1543 – 1553 . 15883169 [138] Yokota , S. , Yokosawa , N. , Okabayashi , T. , Suzutani , T. , Fujii , N. ( 2005 ) Induction of suppressor of cytokine signaling‐3 by herpes simplex virus type 1 confers efficient viral replication. Virology 338 : 173 – 181 . 15939448 [139] Bode , J.G. , Ludwig , S. , Ehrhardt , C. , Albrecht , U. , et al. ( 2003 ) IFN‐alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling‐3. FASEB J 17 : 488 – 490 . 12551851 [140] Samanta , M. , Iwakiri , D. , Kanda , T. , Imaizumi , T. , Takada , K. ( 2006 ) EB virus‐encoded RNAs are recognized by RIG‐I and activate signaling to induce type I IFN. EMBO J. 25 : 4207 – 4214 . 16946700 [141] Elia , A. , Laing , K.G. , Schofield , A. , Tilleray , V.J. , Clemens , M.J. ( 1996 ) Regulation of the double‐stranded RNA‐dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein‐Barr virus genome. Nucleic Acids Res. 24 : 4471 – 4478 . 8948637 [142] Mathews , M.B. , Shenk , T. ( 1991 ) Adenovirus virus‐associated RNA and translation control. J. Virol. 65 : 5657 – 5662 . 1920611 [143] He , B. , Gross , M. , Roizman , B. ( 1997 ) The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double‐stranded RNA‐activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 94 : 843 – 848 . 9023344 [144] Parisien , J.P. , Lau , J.F. , Horvath , C.M. ( 2002 ) STAT2 acts as a host range determinant for species‐specific paramyxovirus interferon antagonism and simian virus 5 replication. J. Virol. 76 : 6435 – 6441 . 12050355 [145] Chatziandreou , N. , Stock , N. , Young , D. , Andrejeva , J. , et al. ( 2004 ) Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J. Gen. Virol 85 : 3007 – 3016 . 15448364 [146] Riffault , S. , Dubuquoy , C. , Castagne , N. , Baranowski , E. , et al. ( 2006 ) Replication of bovine respiratory syncytial virus in murine cells depends on type I interferon‐receptor functionality. J. Gen. Virol 87 : 2145 – 2148 . 16847109 [147] Park , M.S. , Garcia‐Sastre , A. , Cros , J.F. , Basler , C.F. , Palese , P. ( 2003 ) Newcastle disease virus V protein is a determinant of host range restriction. J. Virol. 77 : 9522 – 9532 . 12915566 [148] Wang , F. , Ma , Y. , Barrett , J.W. , Gao , X. , et al. ( 2004 ) Disruption of Erk‐dependent type I interferon induction breaks the myxoma virus species barrier. Nat. Immunol. 5 : 1266 – 1274 . 15502830 [149] Fiola , C. , Peeters , B. , Fournier , P. , Arnold , A. , et al. ( 2006 ) Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence. Int. J Cancer 119 : 328 – 338 . 16470838 [150] Garcia‐Sastre , A. ( 2006 ) Antiviral response in pandemic influenza viruses. Emerg. Infect. Dis. 12 : 44 – 47 . 16494716",
  "plain_text": "Abstract Type I interferons (IFN) including IFNα/β are cytokines of the immune system with critical functions in innate and adaptive immune response. Secreted IFN acts via JAK/STAT signaling pathways to direct a huge gene expression program, including antiviral, apoptotic, survival and immune genes. Only recently, the molecular patterns and their receptors as well as the connected signaling pathways leading to transcriptional activation of IFN genes have been elucidated. Ubiquitous cytosolic RNA helicases like RIG‐I which sense intracellular triphosphate RNAs and activate the IFN‐controlling transcription factors IRF3 and IRF7 seem to play a major role in antiviral defense and immunity. Recognition of extracellular nucleic acids by a subset of Toll‐like receptors in addition contributes to a generalized host IFN response. During co‐evolution with the host, viruses have learned to counteract every piece of the IFN network. Learning from viruses how to target the IFN system may lead us to novel strategies for therapeutic intervention."
}
